Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus

BackgroundFibroblast growth factor 21 (FGF21) has demonstrated beneficial effects on lipid and carbohydrate metabolism. In cross‐sectional studies, an association of raised circulating FGF21 levels with coronary heart disease (CHD) was found in some but not all studies. Here we investigated prospect...

Full description

Bibliographic Details
Main Authors: Chi Ho Lee, Yu Cho Woo, Wing Sun Chow, Chloe Yu Yan Cheung, Carol Ho Yi Fong, Michele Mae Ann Yuen, Aimin Xu, Hung Fat Tse, Karen Siu Ling Lam
Format: Article
Language:English
Published: Wiley 2017-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.005344